Scientists hunt for drug targets in rare kidney disorder
NCT ID NCT06648044
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at the genetic causes of nephronophthisis, a rare kidney disease that leads to kidney failure before age 20. Researchers will collect urine and blood samples from 310 patients and healthy relatives to study cells and identify potential drug targets. The goal is to find new ways to treat this condition, for which no effective therapy currently exists.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could point toward new drug targets for nephronophthisis, a rare kidney disease with no current treatment.
- What could go wrong
- This is an early-stage lab study, not a clinical treatment trial. Findings may not lead to effective therapies for patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOSOMAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Imagine Institute
RECRUITINGLa Defense, France
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.